MoneyWorks4Me

Shalby informs about disclosure

08 Dec 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015, Shalby has informed that the Company's Wholly-owned Subsidiary Mars Medical Devices (MMDL) has further subscribed 2,09,000 equity shares of SGD 1 each in MMDL'S Subsidiary Shalby Global Technologies, Singapore (SGTPL), and remitted funds for the same on December 7, 2021. SGTPL is a subsidiary of Mars Medical Devices and a Step-down Subsidiary of the Company. Shareholding of MMDL in SGTPL is now increased from 96% to 97.82%.

The above information is a part of company’s filings submitted to BSE.


Shalby Share Price

153.55 -3.00 (-1.92%)
14-Aug-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: